Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Orly, Lavee"'
Autor:
Verity Chadwick, Michaela Kim, Georgia Mills, Catherine Tang, Antoinette Anazodo, Rachel Dear, Rachael Rodgers, Orly Lavee, Samuel Milliken, Georgia McCaughan, John Moore, Barbara Withers, Nada Hamad
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:366-372
Background: Chemotherapy predisposes people who menstruate to abnormal uterine bleeding that can be life-threatening and may also damage ovaries, resulting in premature menopause. The purpose of this study was to explore the incidence of menstrual hi
Autor:
Brendan Beaton, Sarah C. Sasson, Katherine Rankin, Juliette Raedemaeker, Alexander Wong, Priyanka Hastak, Chansavath Phetsouphanh, Andrew Warden, Vera Klemm, C. Mee Ling Munier, Alexandra Carey Hoppe, Fiona Tea, Aleha Pillay, Alberto Ospina Stella, Anupriya Aggarwal, Orly Lavee, Ian D. Caterson, Stuart Turville, Anthony D. Kelleher, Fabienne Brilot, Judith Trotman
Publikováno v:
American Journal of Hematology. 98:131-139
Autor:
Abby P, Douglas, Olivia C, Smibert, Ashish, Bajel, Catriona L, Halliday, Orly, Lavee, Brendan, McMullan, Michelle K, Yong, Sebastiaan J, van Hal, Sharon C-A, Chen, Anna, Khanina
Publikováno v:
Internal Medicine Journal. 51:143-176
Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or breakthrough infection, which can become refractory to antifungal treatment and has a high associated mortality. Other emerging patient risk groups include
Autor:
Brendan, Beaton, Sarah C, Sasson, Katherine, Rankin, Juliette, Raedemaeker, Alexander, Wong, Priyanka, Hastak, Chansavath, Phetsouphanh, Andrew, Warden, Vera, Klemm, C Mee Ling, Munier, Alexandra Carey, Hoppe, Fiona, Tea, Aleha, Pillay, Alberto Ospina, Stella, Anupriya, Aggarwal, Orly, Lavee, Ian D, Caterson, Stuart, Turville, Anthony D, Kelleher, Fabienne, Brilot, Judith, Trotman
Publikováno v:
American journal of hematology.
Patients with indolent lymphoma undertaking recurrent or continuous B cell suppression are at risk of severe COVID-19. Patients and healthy controls (HC; N = 13) received two doses of BNT162b2: follicular lymphoma (FL; N = 35) who were treatment naï
Autor:
Helen, Cashman, Sathia, Sushil, Eleni, Mayson, Samuel, Milliken, Orly, Lavee, Alex, Awford, Nada, Hamad
Publikováno v:
The Lancet Haematology. 9:e325-e326
Publikováno v:
Bone Marrow Transplantation. 56:738-740
Introduction: Induction regimens utilising cyclophosphamide, bortezomib and dexamethasone (CyBorD) prior to autologous stem cell transplant are utilised worldwide where access to a combination immunomodulatory agent/proteasome inhibitor approach is l
Publikováno v:
Bone marrow transplantation. 56(3)
Autor:
Joost S.P. Vermaat, Daniel J. McCarthy, Orly Lavee, Sourav Mishra, George A Follows, Krzysztof Warzocha, Theodoros P. Vassilakopoulos, R. Bouabdallah, Ronit Gurion, Marie Maerevoet, Kelly Corona, Federica Cavallo, Miklos Egyed, O. Casasnovas, Josee M. Zijlstra, Andre Goy, Nagesh Kalakonda, Ulrich Jaeger, Michael W. Schuster, A. Oluyadi, Miguel Canales, S. Bakshi, Catherine Thieblemont, Jatin J. Shah, E. Van Den Neste, Sylvain Choquet, Xiwen Ma, Juan-Manuel Sancho, F. de la Cruz, Brian T. Hill, Fritz Offner
Publikováno v:
Hematological Oncology. 37:62-64
Autor:
Georgia McCaughan, Jacinta Perram, Pietro R Di Ciaccio, Orly Lavee, Sam Milliken, Nada Hamad, Barbara Withers, Catherine Tang, Verity L Chadwick, Georgia Mills
Publikováno v:
Blood. 138:3050-3050
Background: Pregnant or breastfeeding women are routinely excluded from clinical trials due to fear of teratogenicity and toxicity of therapeutic agents, despite a paucity of evidence to support this practice. In response to the diethylstilbesterol (
Autor:
Georgia McCaughan, Jacinta Perram, Orly Lavee, Rachel F Dear, Sam Milliken, Barbara Withers, Verity L Chadwick, John Moore, Georgia Mills, Nada Hamad, Pietro R Di Ciaccio, Catherine Tang
Publikováno v:
Blood. 138:4940-4940
Background: Chemotherapy is potentially harmful to the developing foetus and there is limited data on the foetal impact of immunotherapy except for rituximab. Therefore determining pregnancy status prior to initiation of chemo- and or immuno-therapy